Greg Fulcher
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management 36
- Diabetes Management and Research 26
- Diabetes Management and Education 5
- Nephrology top 0.5%
- Surgery top 0.5%
- Pancreatic function and diabetes 19
- Lipoproteins and Cardiovascular Health 4
- Pharmacology top 1%
-
- Metabolism, Diabetes, and Cancer 7
-
- Chronic Disease Management Strategies 5
-
- Potassium and Related Disorders 5
- Co-authors
- Bruce NealVlado PerkovicKenneth W. MahaffeyDick de ZeeuwDavid R. MatthewsWayne ShawMehul DesaiNgozi Erondu
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Greg Fulcher
63 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Endocrinology, Diabetes and Metabolism 7.8k
- Nephrology 1.1k
- Cardiology and Cardiovascular Medicine 1.8k
- Surgery 3.4k
- Pharmacology 873
Countries citing papers authored by Greg Fulcher
This map shows the geographic impact of Greg Fulcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Fulcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Fulcher more than expected).
Fields of papers citing papers by Greg Fulcher
This network shows the impact of papers produced by Greg Fulcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Fulcher. The network helps show where Greg Fulcher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Greg Fulcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 59 | |
| 2 | 2019 | 101 | |
| 3 | 2019 | 0 | |
| 4 | 2019 | 90 | |
| 5 | 2018 | 20 | |
| 6 | 2018 | 1 | |
| 7 | 2018 | 9 | |
| 8 | Canagliflozin for Primary and Secondary Prevention of Cardiovascular Eventsbreakdown → | 2017 | 375 |
| 9 | Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetesbreakdown → | 2017 | 5379 |
| 10 | 2016 | 25 | |
| 11 | 2016 | 100 | |
| 12 | 2016 | 33 | |
| 13 | 2015 | 23 | |
| 14 | 2013 | 53 | |
| 15 | 2011 | 101 | |
| 16 | Insulin degludec, a new generation ultra-long acting insulin, used once daily or 3-times weekly in people with type 2 diabetes: comparison to insulin glargine | 2010 | 5 |
| 17 | 2008 | 10 | |
| 18 | 2008 | 397 | |
| 19 | 2004 | 99 | |
| 20 | 1997 | 7 |
About Greg Fulcher
Greg Fulcher is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery, having authored 65 papers that have together received 9.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (36 papers), Diabetes Management and Research (26 papers), Pancreatic function and diabetes (19 papers), Metabolism, Diabetes, and Cancer (7 papers), Chronic Disease Management Strategies (5 papers), Diabetes Management and Education (5 papers), Potassium and Related Disorders (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.8k citations), Nephrology (1.1k citations) and Cardiology and Cardiovascular Medicine (1.8k citations). Greg Fulcher has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, David R. Matthews, Wayne Shaw, Mehul Desai, Ngozi Erondu, Gordon Law and Terrance D. Barrett. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Circulation, Diabetologia and Diabetes Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.